Pfizer to acquire Biohaven in $11.6B bet on biotech's migraine …

Pfizer To Acquire Biohaven In $11.6B Bet On Biotech's Migraine …

1 week from now

May 10, 2022  · Dan Kitwood via Getty Images. Pfizer has agreed to acquire Biohaven Pharmaceuticals for $11.6 billion in a deal that turns an existing alliance on a fast-selling …

biopharmadive.com

Pfizer Completes Acquisition Of Biohaven Pharmaceuticals

1 week from now

Oct 3, 2022  · Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately …

pfizer.com

Pfizer Buys Its Way Into Migraine With $11.6B Biohaven Pharma ...

1 week from now

May 10, 2022  · Pfizer grabbed a stake in Biohaven Pharmaceuticals last fall when it partnered with the company on the commercialization of oral migraine drug Nurtec. Now the …

medcitynews.com

Pfizer To Buy Biohaven Pharmaceutical In $11.6 Bln Deal

1 week from now

May 10 (Reuters) - Pfizer Inc PFE.N said on Tuesday it will buy migraine drug maker Biohaven Pharmaceutical Holding Company Ltd BHVN.N for about $11.6 billion in cash. Pfizer will …

nasdaq.com

Pfizer Buys Biohaven’s Migraine Drugs For $11.6 Billion - Nature

1 week from now

May 20, 2022  · Pfizer bagged a pipeline of calcitonin gene-related peptide (CGRP)-targeted drugs with its US$11.6 billion acquisition of Biohaven. The most advanced of these is the FDA …

nature.com

Pfizer To Buy Biohaven For $11.6 Billion | C&EN Global Enterprise

1 week from now

May 16, 2022  · Seeking Nurtec, a pill approved to treat and prevent migraine in adults, Pfizer has agreed to acquire its maker, Biohaven Pharmaceuticals, in a cash deal valued at $11.6 billion. …

acs.org

Biohaven Starts Life As New Company Following Pfizer Buyout

1 week from now

Oct 5, 2022  · Pfizer will owe Biohaven royalties on sales of the Biohaven migraine drugs Nurtec ODT and zavegepant that it held onto as part of its acquisition, should they exceed $5.25 …

biopharmadive.com

Pfizer Buys Biohaven's Migraine Drugs For $11.6 Billion - PubMed

1 week from now

Pfizer buys Biohaven's migraine drugs for $11.6 billion. Pfizer buys Biohaven's migraine drugs for $11.6 billion Nat Rev Drug Discov. 2022 Jul;21(7):480. doi: 10.1038/d41573-022-00093-3. …

nih.gov

Two Years After Selling Its Migraine Assets To Pfizer In $13B Deal, …

1 week from now

Oct 28, 2024  · Fast-forward to 2022, when pharmaceutical giant Pfizer Inc. completed its $11.6 billion acquisition of those migraine therapeutic assets, while also paying off Biohaven’s debt, …

hartfordbusiness.com

Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout ...

1 week from now

Feb 2, 2023  · ALLISON GATLIN. 05:10 PM ET 02/02/2023. Biohaven (BHVN) is following the same strategy with its remaining drug pipeline as it did prior to Pfizer 's (PFE) massive buyout …

investors.com

Pfizer To Acquire Biohaven Pharmaceuticals

1 week from now

Under the terms of the agreement, Pfizer will acquire all outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash. Biohaven common shareholders, …

pfizer.com

Pfizer’s Biohaven Deal Pays Dividends With New Drug Approval

1 week from now

Mar 10, 2023  · The Food and Drug Administration on Friday approved a new migraine medicine from Pfizer, bolstering the roughly $12 billion bet the company made on the drug’s developer, …

biopharmadive.com

Biohaven And Pfizer Complete Collaboration Transaction For ...

1 week from now

$150 million cash and $350 million in the purchase of Biohaven equity. At close, Pfizer will own 3% of Biohaven. Biohaven is also eligible to receive up to $740 million in future milestones. In …

pfizer.com